Lorraine Scanlon, MD, is an SUO fellow at London Health Sciences Center in London, Ontario, Canada

Lorraine Scanlon, MD

Lorraine Scanlon, MD, of Trinity College Dublin, discussed the incidence, management, and physiologic implications of inferior vena cava (IVC) tumor thrombus in patients with renal cell carcinoma (RCC), as well as emerging consideration of venous decompression as a therapeutic strategy.

She noted that IVC tumor thrombus occurs in approximately 4% to 10% of patients with RCC, making it an uncommon but clinically important presentation that requires specialized multidisciplinary management.

Standard treatment consists of radical nephrectomy with IVC thrombectomy, with surgical complexity determined by the cranial extent of the thrombus. Preoperative imaging and meticulous operative planning are critical, particularly for higher-level thrombi that may require vascular bypass techniques or liver mobilization. Scanlon emphasized that although the procedure is performed primarily for oncologic control, the physiologic effects of relieving venous obstruction may have meaningful implications for postoperative renal function.

She explained that in patients with IVC tumor thrombus, venous outflow obstruction from the affected kidney results in elevated renal venous pressure, leading to interstitial edema and impaired glomerular filtration. This constellation produces a form of reversible hemodynamic renal dysfunction, which is distinct from chronic kidney disease. Importantly, she noted that renal function often improves following nephrectomy and thrombectomy, supporting the concept that obstruction-induced renal impairment may be at least partially reversible when venous drainage is restored.

Scanlon highlighted that this observation has prompted interest in whether relief of venous congestion itself may serve as a therapeutic avenue, independent of oncologic resection. Understanding the hemodynamic consequences of renal venous obstruction, particularly its impact on filtration gradients and renal perfusion, could help refine patient selection for surgery and guide perioperative management. For example, in select patients who are not candidates for immediate tumor resection, targeted approaches to relieve venous pressure might potentially stabilize renal function or improve overall physiologic reserve before definitive therapy.

She also noted that improved characterization of the mechanisms behind venous congestion could inform future research assessing whether partial or staged interventions may offer benefit. This could include exploration of novel vascular techniques or adjunctive approaches designed to mitigate renal venous hypertension.

Scanlon concluded that while nephrectomy with IVC thrombectomy remains the cornerstone of management, ongoing investigation into the physiologic effects of venous obstruction may broaden understanding of RCC-associated renal dysfunction and support new avenues for therapeutic intervention.

Videos

Lorraine Scanlon, MD, discusses IVC tumor thrombus in RCC, its management, and how relieving venous congestion may improve renal function and guide future care.

Lorraine Scanlon, MD

Articles

Dr Scanlon on the Incidence, Management, and Physiologic Impact of IVC Tumor Thrombus in RCC